Stay updated on SAGE-217 for Severe Depression Clinical Trial
Sign up to get notified when there's something new on the SAGE-217 for Severe Depression Clinical Trial page.

Latest updates to the SAGE-217 for Severe Depression Clinical Trial page
- Check2 days agoChange DetectedA sitewide NIH notice announces a transition in terminology, saying federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” under Executive Order 14434.SummaryDifference1%

- Check9 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 on the ClinicalTrials.gov 403 error page. The displayed error content and layout remain unchanged.SummaryDifference0.2%

- Check16 days agoChange DetectedThe footer revision label was updated from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check30 days agoChange DetectedThe study page now shows a 403 Forbidden error, blocking access to the record. The page displays the standard header and footer while the main content area shows the access-denied message.SummaryDifference0.5%

- Check37 days agoChange DetectedThe study page now displays a 403 Forbidden error page instead of the study record content, indicating access is blocked. This changes the user experience by presenting an error screen rather than the study details and related information.SummaryDifference26%

- Check59 days agoChange DetectedRevision bump from v3.6.5 to v3.6.6; this update represents a software version update rather than a content change on the page.SummaryDifference0.0%

Stay in the know with updates to SAGE-217 for Severe Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-217 for Severe Depression Clinical Trial page.